5-oxygenated HMG-CoA reductase inhibitors
US4963538A · kind A · utility
20Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 1989 |
| Grant date | Oct 16, 1990 |
| Priority date | — |
| Expiry date | Mar 13, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel HMG-CoA reductase inhibitors are useful as antihypercholesterolemic agents and are represented by structural formulae (I) or (II): ##STR1## wherein position 5 of the polyhydronaphthyl ring is singly or doubly bonded to oxygen or incorporated into a C.sub.3-7 carbocyclic ring.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.